Revolutionary Aphrodesiac Enters Phase 3
Instant sex in a bottle? PT-141 is a drug in development that reportedly increases sexual desire and performance in men and women. Bremelanotide is a derivative of Melanotan II, a substance originally used as a sunless tanning agent. Researchers noticed that although it did give you a tan, it had unexpected side effects. Those being sexual arousal and spontaneous erections. PT-141 does not come with many of the side effects associated with other 'sex drugs" because it acts on the brain and not the vascular system.
Trend Themes
1. Sexual Enhancement Drugs - Disruptive innovation opportunity: Developing safer and more effective alternatives to traditional 'sex drugs'.
2. Neuropharmacology - Disruptive innovation opportunity: Exploring the potential of brain-targeted drugs for enhancing sexual desire and performance.
3. Personal Care Products - Disruptive innovation opportunity: Creating innovative topical solutions that can have unexpected positive side effects, such as increased sexual arousal.
Industry Implications
1. Pharmaceuticals - Disruptive innovation opportunity: Developing and commercializing PT-141 and other novel drugs for sexual enhancement.
2. Health and Wellness - Disruptive innovation opportunity: Integrating neuropharmacology and innovative personal care products to meet the growing demand for sexual enhancement solutions.
3. Cosmetics - Disruptive innovation opportunity: Incorporating ingredients with unexpected positive side effects, like increased sexual arousal, into personal care and cosmetic products.
3.5
Score
Popularity
Activity
Freshness
